Polar Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-60,000
| Closed | -$7.26M | – | 254 |
|
|
2017
Q2 | $7.26M | Buy |
60,000
+25,000
| +71% | +$3.03M | 0.1% | 163 |
|
|
2017
Q1 | $3.96M | Buy |
35,000
+1,500
| +4% | +$170K | 0.06% | 195 |
|
|
2016
Q4 | $3.64M | Buy |
33,500
+10,500
| +46% | +$1.14M | 0.06% | 204 |
|
|
2016
Q3 | $3.79M | Buy |
23,000
+1,131
| +5% | +$186K | 0.07% | 192 |
|
|
2016
Q2 | $3.12M | Buy |
+21,869
| New | +$3.12M | 0.06% | 203 |
|
|
2016
Q1 | – | Sell |
-13,921
| Closed | -$2.08M | – | 284 |
|
|
2015
Q4 | $2.08M | Buy |
13,921
+462
| +3% | +$69K | 0.04% | 212 |
|
|
2015
Q3 | $2.23M | Buy |
13,459
+3,631
| +37% | +$602K | 0.05% | 213 |
|
|
2015
Q2 | $2.37M | Buy |
9,828
+453
| +5% | +$109K | 0.05% | 220 |
|
|
2015
Q1 | $2.64M | Buy |
9,375
+1,933
| +26% | +$545K | 0.05% | 210 |
|
|
2014
Q4 | $1.16M | Buy |
7,442
+5,787
| +350% | +$903K | 0.02% | 228 |
|
|
2014
Q3 | $392K | Buy |
+1,655
| New | +$392K | 0.01% | 250 |
|
|
2014
Q1 | – | Sell |
-267,692
| Closed | -$18.3M | – | 279 |
|
|
2013
Q4 | $18.3M | Buy |
267,692
+87,692
| +49% | +$5.99M | 0.43% | 75 |
|
|
2013
Q3 | $124K | Sell |
180,000
-127,070
| -41% | -$87.7K | 3.32% | 2 |
|
|
2013
Q2 | $13.8M | Buy |
+307,070
| New | +$13.8M | 0.48% | 69 |
|